Literature DB >> 6493281

Tamoxifen in the treatment of refractory lymphoma.

P Narasimhan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6493281     DOI： 10.1056/NEJM198411083111917

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Improvement in the POEMS syndrome after administration of tamoxifen.

Authors:  T P Enevoldson; A E Harding
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-01       Impact factor: 10.154

2.  Stabilisation of a severe case of P.O.E.M.S. syndrome after tamoxifen administration.

Authors:  J H Barrier; H Le Noan; J M Mussini; J M Brisseau
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-02       Impact factor: 10.154

3.  Fatty acid modulation of antiestrogen action and antiestrogen-binding protein in cultured lymphoid cells.

Authors:  Y K Hoh; E H Lim; S O Ooi; O L Kon
Journal:  Experientia       Date:  1990-10-15

4.  Tamoxifen increases photodynamic therapeutic response of U87 and U25ln human glioma cells.

Authors:  Feng Jiang; Kyung-Keun Cho; Tom Mikkelse; Ling Tong; Young S Lew; Nechama Hochbaum; Josef Shargorodsky; Michael Chop
Journal:  J Neurooncol       Date:  2002-01       Impact factor: 4.130

5.  Histiocytic lymphoma of breast responds to tamoxifen.

Authors:  R R Millis; L G Bobrow; R D Rubens; P G Isaacson
Journal:  Br J Cancer       Date:  1988-12       Impact factor: 7.640

6.  Inhibitory effects of tamoxifen and doxorubicin, alone and in combination, on the proliferation of the MG63 human osteosarcoma cell line.

Authors:  Zheng-Xiao Ouyang; Xian-An Li
Journal:  Oncol Lett       Date:  2013-07-24       Impact factor: 2.967
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.